USE OF INTRAVENOUS FK506 TO TREAT ACUTE REJECTION IN SIMULTANEOUS PANCREAS-KIDNEY TRANSPLANT RECIPIENTS ON MAINTENANCE ORAL FK506

Gaetano Ciancio, George W. Burke, David Roth, Joshua Miller

Transplantation · 1997 · 18 citations · 6 references

Concepts

Abstract

Most recipients of simultaneous pancreas-kidney transplants experience acute rejection in the early postoperative course. We report our experience with four recipients of simultaneous pancreas-kidney transplants with acute rejection who were effectively treated with the combination of intravenous and oral FK506 therapy. This spared these patients an extra course of monoclonal or polyclonal antibody.

References

6